|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
96
|
|
pubmed:dateCreated |
2004-10-29
|
|
pubmed:abstractText |
The aim of the study was evaluation the HBeAg/antiHBe seroconversion frequency as a result of lamivudine treatment in children who are nonresponders to previous IFN-alpha therapy.
|
|
pubmed:language |
pol
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1426-9686
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
557-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15510896-Adolescent,
pubmed-meshheading:15510896-Antiviral Agents,
pubmed-meshheading:15510896-Child,
pubmed-meshheading:15510896-Child, Preschool,
pubmed-meshheading:15510896-Female,
pubmed-meshheading:15510896-Hepatitis B, Chronic,
pubmed-meshheading:15510896-Hepatitis B Antibodies,
pubmed-meshheading:15510896-Hepatitis B e Antigens,
pubmed-meshheading:15510896-Humans,
pubmed-meshheading:15510896-Interferon-alpha,
pubmed-meshheading:15510896-Lamivudine,
pubmed-meshheading:15510896-Male,
pubmed-meshheading:15510896-Time Factors,
pubmed-meshheading:15510896-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
[The HBeAg/antiHBe seroconversion as a result of lamivudine treatment in children with chronic hepatitis B unresponsive to previous interferon alpha therapy].
|
|
pubmed:affiliation |
III Klinika Chorób Dzieci AM w Bia?ymstoku.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|
